Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapy

A major clinical problem in the use of cisplatin to treat cancers is tumor resistance. DNA polymerase η (Polη) is a key polymerase that allows cancer cells to cope with cisplatin–DNA adducts formed during chemotherapy. We present here a structure of human Polη inserting dCTP opposite a cisplatin int...

Descripción completa

Detalles Bibliográficos
Autores principales: Ummat, Ajay, Rechkoblit, Olga, Jain, Rinku, Choudhary, Jayati R., Johnson, Robert E., Silverstein, Timothy D., Buku, Angeliki, Lone, Samer, Prakash, Louise, Prakash, Satya, Aggarwal, Aneel K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502009/
https://www.ncbi.nlm.nih.gov/pubmed/22562137
http://dx.doi.org/10.1038/nsmb.2295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502009/
https://www.ncbi.nlm.nih.gov/pubmed/22562137
http://dx.doi.org/10.1038/nsmb.2295

Ejemplares similares